These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6424696)

  • 1. Biochemical alterations in the mouse induced by Pseudomonas aeruginosa and its slime glycolipoprotein.
    Lynn M; Lotz L
    Br J Exp Pathol; 1984 Apr; 65(2):275-81. PubMed ID: 6424696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological study of glycolipoprotein isolated from extracellular slime of different Pseudomonas aeruginosa serogroups.
    Stanislavsky ES; Kholodkova EV; Youshkova NA; Yourokova IB; Zhvanetskaya MI
    Acta Microbiol Hung; 1986; 33(1):55-67. PubMed ID: 3092559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serologic and protective cross-reactivity of antisera to Pseudomonas aeruginosa extracellular slime glycolipoprotein.
    Yushkova NA; Kholodkova EV; Korobova TS; Stanislavsky ES
    Acta Microbiol Hung; 1986; 33(2):147-56. PubMed ID: 3101393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Histologic study of corneal lesions caused by the slime-GLP glycolipoprotein of Pseudomonas aeruginosa].
    Pharmakakis N; Papadakis E; Gartaganis S; Bechrakis M; Dimitracopoulos G; Varakis I
    Ophtalmologie; 1990; 4(1):72-5. PubMed ID: 2123533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological alterations in mice induced by Pseudomonas aeruginosa slime glycolipoprotein.
    Papadaki HI; Dimitracopoulos G; Bonicos D; Petrou G; Anastassiou ED
    J Exp Pathol; 1990; 5(1):7-18. PubMed ID: 2118950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of the biologic activity of surface slime in experimental Pseudomonas aeruginosa infections.
    Bartell PF
    Rev Infect Dis; 1983; 5 Suppl 5():S971-8. PubMed ID: 6419319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbohydrate mediation of the biological activities of the glycolipoprotein of Pseudomonas aeruginosa.
    Orr T; Koepp LH; Bartell PF
    J Gen Microbiol; 1982 Nov; 128(11):2631-8. PubMed ID: 6818328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological study of Pseudomonas aeruginosa extracellular slime.
    Stanislavsky ES; Yushkova NA; Edvabnaya LS; Landsman NM; Zaidner IG
    Acta Microbiol Hung; 1985; 32(1):49-59. PubMed ID: 2412390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of anti-slime glycolipoprotein serum on the interaction between Pseudomonas aeruginosa and macrophages.
    Bartell PF; Krikszens A
    Infect Immun; 1980 Mar; 27(3):777-83. PubMed ID: 6769808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo distribution of Pseudomonas aeruginosa slime glycolipoprotein: association with leukocytes.
    Lynn M; Sensakovic JW; Bartell PF
    Infect Immun; 1977 Jan; 15(1):109-14. PubMed ID: 401769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the alternative pathway of human complement by the extracellular slime glycolipoprotein of Pseudomonas aeruginosa.
    Lambris J; Papamichail M; Ioannidis C; Dimitracopoulos G
    J Infect Dis; 1982 Jan; 145(1):78-82. PubMed ID: 6798132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phagocytosis and killing of Pseudomonas aeruginosa by mouse polymorphonuclear leukocytes in vitro promoted by antiserum to the slime glycolipoprotein.
    Bishop O; Orr T; Bartell PF
    Infect Immun; 1982 Jul; 37(1):378-81. PubMed ID: 6809634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Slime glycolipoproteins and the pathogenicity of various strains of Pseudomonas aeruginosa in experimental infection.
    Dimitracopoulos G; Bartell PF
    Infect Immun; 1980 Nov; 30(2):402-8. PubMed ID: 6777303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polysaccharide of the slime glycolipoprotein of Pseudomonas aeruginosa.
    Koepp LH; Orr T; Bartell PF
    Infect Immun; 1981 Sep; 33(3):788-94. PubMed ID: 6793519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of mitogenicity and basement-membrane-degrading activity of Pseudomonas aeruginosa slime glycolipoprotein and alginate.
    Anastassiou ED; Karakiulakis G; Missirlis E; Maragoudakis ME; Dimitracopoulos G
    J Clin Microbiol; 1989 Mar; 27(3):490-4. PubMed ID: 2497138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective activity of immune sera against extracellular slime from Pseudomonas aeruginosa on experimental infection in mice.
    Sokalska M; Maresz-Babczyszyn J
    Arch Immunol Ther Exp (Warsz); 1981; 29(5):643-52. PubMed ID: 6812542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outer membrane proteins of Pseudomonas aeruginosa as vaccine candidates.
    von Specht BU; Domdey H; Schödel F; Blum B; Lücking C; Knapp B; Muth G; Hungerer KD; Bröker M
    Behring Inst Mitt; 1994 Dec; (95):85-96. PubMed ID: 7538752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on phagocytosis of mucoid and nonmucoid variants of Pseudomonas aeruginosa. II. Induction of heterologous immunity by mucoid strains of P. aeruginosa.
    Gościniak G; Grzybek-Hryncewicz K
    Arch Immunol Ther Exp (Warsz); 1988; 36(2):185-93. PubMed ID: 3149177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical composition of the extracellular slime glycolipoprotein of Pseudomonas aeruginosa and its relation to gentamicin resistance.
    Arsenis G; Dimitracopoulos G
    J Med Microbiol; 1986 May; 21(3):199-202. PubMed ID: 3084789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection.
    Zaidi TS; Priebe GP; Pier GB
    Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.